Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0000950170-25-026076
Filing Date
2025-02-25
Accepted
2025-02-25 07:30:30
Documents
113
Period of Report
2024-12-31

Document Format Files

Seq Description Document Type Size
1 10-K beam-20241231.htm   iXBRL 10-K 4516891
2 EX-10.18 beam-ex10_18.htm EX-10.18 107288
3 EX-10.42 beam-ex10_42.htm EX-10.42 71503
4 EX-19.1 beam-ex19_1.htm EX-19.1 108635
5 EX-23.1 beam-ex23_1.htm EX-23.1 4229
6 EX-31.1 beam-ex31_1.htm EX-31.1 30388
7 EX-31.2 beam-ex31_2.htm EX-31.2 31209
8 EX-32.1 beam-ex32_1.htm EX-32.1 9512
9 EX-32.2 beam-ex32_2.htm EX-32.2 10819
10 GRAPHIC img43983261_0.jpg GRAPHIC 103981
11 GRAPHIC img43983261_1.jpg GRAPHIC 709468
12 GRAPHIC img245850697_0.jpg GRAPHIC 7415
  Complete submission text file 0000950170-25-026076.txt   19479546

Data Files

Seq Description Document Type Size
13 XBRL TAXONOMY EXTENSION SCHEMA WITH EMBEDDED LINKBASES DOCUMENT beam-20241231.xsd EX-101.SCH 2362899
116 EXTRACTED XBRL INSTANCE DOCUMENT beam-20241231_htm.xml XML 3220970
Mailing Address 26 LANDSDOWNE STREET CAMBRIDGE MA 02139
Business Address 26 LANDSDOWNE STREET CAMBRIDGE MA 02139 857-327-8775
Beam Therapeutics Inc. (Filer) CIK: 0001745999 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 001-39208 | Film No.: 25659408
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)